Prudential Bank champions prostate cancer awareness and support in Ghana
Prudential Bank Limited (PBL) has intensified its commitment to raising awareness and supporting prostate cancer patients through a series of impactful activities.
The campaign is part of the Bank’s Prostate Cancer Awareness Month initiatives aimed at recognising the importance of education, early detection, and community support.
To this end, Prudential Bank has provided access to free prostate cancer screenings across several cities, including Accra, Tema, Cape Coast, Takoradi, Kumasi, Koforidua, Tamale, and Sunyani.
The initiative saw over a thousand men take advantage of the opportunity for early testing.
Commenting on the campaign, Ms Jamilla Disu, Marketing and Corporate Affairs Department, Prudential Bank, said the screenings sought to increase awareness about the importance of regular check-ups, especially among men over 40, who are at a higher risk of developing prostate cancer.
“By bringing these essential services closer to the communities, the bank hopes to encourage more men to prioritise their health and seek early intervention,” she said.
As part of its overall prostate cancer support initiatives, Prudential Bank also presented a donation of GH¢30,000 to the National Radiotherapy Oncology and Nuclear Medicine Centre at Korle Bu Teaching Hospital.
This contribution, she said, was aimed at assisting the Centre in providing affordable treatment options for prostate cancer patients who may struggle with the financial burden of long-term care.
Moreover, she said the funds were expected to help the Centre in its mission to deliver quality healthcare and support for patients in Ghana and the wider sub-region.
Prof. Joel Yarney, Director of the National Radiotherapy Oncology and Nuclear Medicine Centre, expressed his appreciation to Prudential Bank, noting that the financial assistance would provide much-needed relief to patients and their families.
Prof. Yarney highlighted that prolonged cancer treatment often imposed a significant financial strain on patients, making corporate support vital for the Centre’s continued efforts in delivering high-quality healthcare.